GLP-1 6-in-1: What It Is and Whether It Works (October 2026)

01 · The short answer

What is GLP-1 6-in-1, and is it a real GLP-1 medicine?

No: it is not a licensed GLP-1 medicine. The names you see, such as GLP-1 6-in-1 liquid, all-in-one, seven-in-one and nine-in-one, describe multi-ingredient products sold as drops or blends. They are marketed with the language of GLP-1 treatments, but the name alone does not make them one. A medicine is only a GLP-1 treatment in the UK if it holds a UK licence and is supplied under prescription.

The licensed options are tirzepatide (Mounjaro), which activates both GIP and GLP-1 receptors, and semaglutide (Wegovy), alongside the daily injection liraglutide. Each was tested in published clinical trials, and each is prescription-only. A supplement blend has none of that behind it, so the weight-loss figures you read for the licensed medicines cannot be borrowed for a bottle of drops.

Ingredient lists, strengths and quality vary between sellers and are not standardised, so you cannot know what is in any particular 6-in-1 bottle. That uncertainty is itself the main practical problem. If you cannot say what you are taking, you cannot judge whether it is safe alongside your other medicines or conditions.

02 · Your decision

Should you try it, or look at licensed treatment?

If you want a treatment that has been tested for weight management, the licensed route is the one with evidence. Mounjaro is licensed in the UK for weight management in adults and for type 2 diabetes, and it is used alongside a reduced-calorie diet and increased physical activity.¹ Results vary from person to person, and it is not suitable for everyone, which is why a prescriber reviews each order.

If cost is what draws you to low-cost drops, compare like for like. A supplement's cheapness is a reason for caution rather than a saving, because no clinical oversight comes with it and no trial results apply.

A sensible rule: do not start any product that promises dramatic results, hides its ingredients, or is sold to you without any health questions. If a seller offers to supply a GLP-1 medicine without a consultation or prescription, treat it as a red flag.

03 · Next steps

What to do next

Start by asking what you actually want: a licensed treatment you can trust, or reassurance about a product you already bought. For the first, our weight loss clinic explains the route from free consultation to delivery. For the second, stop and check the label, keep the packaging, and speak to a pharmacist or your GP if you feel unwell. If you want to read more, see our page on reviews of 6-in-1 drops and the seven-in-one version. Our guide to all-in-one GLP-1 products covers the same family of names.

04 · What the name means

What the 6-in-1 name actually means

The "6-in-1" label describes how a product is packaged and sold, not how it works. It suggests several ingredients combined in one bottle of liquid drops, and sellers use it alongside variants such as all-in-one, seven-in-one and nine-in-one. Those numbers are marketing counts. They are not doses, strengths or clinical categories, and there is no regulator-approved definition behind them.

First, GLP-1 is the name of a natural gut hormone. Second, GLP-1 medicines are carefully developed prescription drugs designed to act on the receptors for that hormone. Third, supplement products use the "GLP-1" term in their names or advertising, usually to imply that they support the same pathways. Only the second group are medicines with a licence. Using a hormone's name in a product title is not evidence that the product does anything similar.

Many of these listings use phrases like "natural GLP-1 support", "metabolic blend" or "nature's alternative". Those phrases are chosen because they sound clinical without making a claim a regulator would test. If you read a listing closely, you will often find that it never says the product contains a GLP-1 medicine, only that it "supports" something. That wording gap is the whole trick.

Because supplement blends are not standardised, two bottles with the same name can differ in what they contain and how much. Dosing is not standardised, ingredient quality is not independently tested the way a licensed medicine is, and the seller is often an overseas marketplace store you cannot easily contact. None of that is the same as the controlled manufacture and UK supply chain behind a licensed pen.

The practical takeaway is simple. Treat "GLP-1 6-in-1" as a brand-style label for a supplement, read the ingredient panel yourself, and never assume it is a substitute for, or a cheaper version of, a prescription treatment.

It is also worth knowing that similar names are used by completely different sellers. A good review of one bottle says nothing about another that shares the same title, so a name is not a reliable way to identify a product.

05 · Real GLP-1 medicines

How real GLP-1 medicines work

Licensed GLP-1 treatments are prescription medicines with a defined mechanism, a tested dose range and a published safety profile. Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet. This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).¹

Semaglutide, sold for weight management as Wegovy, is a once-weekly pen with a stepped dose ladder: 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg. Liraglutide, supplied at 6mg/ml, is different again: it is a daily injection rather than a weekly one.

What these medicines share is a regulated route. The product has a licence, the pen has a batch and expiry date, the prescriber checks suitability, and ongoing reviews adjust the dose. A supplement blend has no equivalent for any of those steps. The reason liquid drops are not a like-for-like substitute is not a small technical difference. It is the difference between a tested, supervised medicine and an unregulated consumer product.

You can read more about how the dose is delivered from a pen in our explainer on how much liquid is in one Mounjaro dose. The measurable, repeatable dosing of a pen is exactly what a bottle of drops cannot offer.

One more practical difference: a licensed pen is used on a set schedule, with the prescriber involved when you step up or settle on a dose. With drops, there is usually nobody checking in at all, so problems tend to go unnoticed until they are already a concern.

06 · What the evidence shows

What the evidence shows, and what it does not

The weight-loss figures that circulate online come from trials of licensed medicines, and they cannot be transferred to supplements. The best-known tirzepatide trial is SURMOUNT-1. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

Notice what that sentence needs to be meaningful: a named trial, a defined medicine, specific doses, a stated duration and a comparison group. A bottle of drops has none of these. When a listing quotes impressive-sounding results, ask three questions. Which trial? Which product was tested? Was it the same formula you are buying? If the answers are missing, the claim has no evidence behind it.

Only SURMOUNT-5 supports a direct comparison between tirzepatide and semaglutide, and its design is specific to that question.¹⁵ Trial averages do not predict your own result, and some people lose less than the average.

So what can honestly be said about 6-in-1 drops? Absence of evidence is not proof of harm, but it is a poor basis for spending money or for delaying proper treatment if you need it.

If you are curious about longer-term experience on a licensed medicine rather than a supplement, our page on six months on GLP-1 treatment looks at what people can realistically expect over that period, with the same emphasis on individual variation.

In short, evidence has to belong to the exact product you are using. For licensed medicines it does; for blends sold under a GLP-1 name it does not.

07 · Reading reviews and claims

How to read reviews and marketing claims

Online reviews of 6-in-1 drops are a weak guide, because they cannot show what was in the bottle, what else the person changed, or whether the review is genuine. A positive review may reflect a change in diet, a placebo response, or a paid listing. A negative one may reflect a poor-quality batch from a different seller using the same product name. Neither tells you how the product behaves in your body.

Look for dramatic weight-loss claims presented as certain; a short or missing ingredient list; no named manufacturer or UK contact address; claims that a product is "the same as" or "better than" a prescription medicine; and phrases such as "no prescription needed" or "no consultation". Any one of these should slow you down.

Another red flag is a seller that mixes supplement language with real drug names, for example suggesting that a bottle of drops contains semaglutide or tirzepatide. The MHRA publishes counterfeit medicine alerts and runs the Yellow Card scheme for reporting problems, and it is the right place to look if you suspect a product is fake or unsafe.⁷ A genuine prescription GLP-1 medicine is not sold as a drop or a food-style blend and is not sold without a consultation or prescription.

A useful habit is to separate the claim from the proof. If a listing says a product works, look for the document that shows it: a trial, a licence number, a regulator entry. For licensed pharmacies you can check the register. Ours is GPhC 9012878, and you can verify any UK pharmacy the same way through the GPhC public register.¹²

If a product leaves you feeling unwell, stop using it, keep the packaging and tell a pharmacist or doctor. Reporting through Yellow Card helps the regulator spot problems early.

08 · Safety and counterfeits

Safety, counterfeits and where to report problems

The main safety issue with 6-in-1 drops is uncertainty: you cannot be sure what you are taking, and nobody is checking whether it suits you. A licensed prescription medicine comes with a patient information leaflet, a known side-effect profile and a prescriber who reviews your health before supply.¹³ A supplement sold on a marketplace may offer none of that, and you may not be able to trace the seller if something goes wrong.

Counterfeits are a separate risk. Fake or diverted GLP-1 products have been the subject of regulator warnings, and the MHRA provides counterfeit medicine alerts and a way to report suspect products.⁷ If you want a genuine pen, buy only from a pharmacy that is on the GPhC register and that asks about your health before supplying. Our Mounjaro comes via official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens.

Side effects with licensed GLP-1 medicines are documented in the product information, and the leaflet is the place to read the full list before you start. Serious side effects are uncommon but need urgent attention. Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of the skin or eyes (possible gallbladder problems); or signs of a severe allergic reaction. If you experience a new or worrying symptom on any product, speak to your prescriber or pharmacist, and report the suspected side effect to the Yellow Card scheme.¹⁹

Do not combine unknown supplements with prescription medicines without checking with a pharmacist first. Insulin and some other diabetes medicines are a particular example where doses may need adjusting under medical supervision when starting a licensed GLP-1 medicine, which is exactly the kind of oversight a bottle of drops will not give you.

If you are already taking a 6-in-1 product and are thinking of moving to licensed treatment, tell the prescriber in the consultation. Honest information about everything you take is what makes a safe decision possible.

Finally, never share pens or buy a medicine intended for someone else. A prescription is individual to the person it was written for.

09 · NHS versus private

NHS and private routes to a real GLP-1 medicine

If the appeal of 6-in-1 drops is that they feel easy to reach, it is worth knowing how licensed treatment can be accessed. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions). Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.⁴⁶

Your first step on the NHS is a conversation with your GP, who can tell you whether you fall into a group currently being offered treatment locally. The NHS also publishes plain-language information about the medicine itself.⁵ NHS access to Wegovy runs through specialist weight-management services; ask your GP.

For private treatment, the route is straightforward and regulated. You complete a free online consultation, which is a short health questionnaire with no charge and no obligation. A GPhC-registered prescriber reviews your answers, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Approved orders are dispensed by our registered pharmacy, with same-day dispatch when ordered by 3pm, and free next-day tracked delivery in discreet, temperature-controlled packaging.

Needles, a sharps bin and injection guidance are included with every order, and ongoing monthly reviews, dose titration and follow-up assessments are part of the aftercare, with side-effect support from the prescribing team. Repeat orders re-check suitability, and there is no auto-shipping. Payment options include Visa and Mastercard, Klarna and pay-monthly plans, with no subscription lock-in.

The consultation is free and the price shown is the price paid, with no hidden fees.

You can explore the full set of options on our weight loss clinic page or go straight to the Mounjaro pen and consultation.

10 · Comparing licensed options

Comparing the licensed alternatives

If you are weighing up what to use instead of drops, the sensible comparison is between licensed medicines. Mounjaro (tirzepatide) is a once-weekly pen with six strengths from 2.5mg to 15mg.¹ Wegovy (semaglutide) is also once weekly, with a ladder of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, stepping up after at least four weeks to the 2.4mg maintenance dose from week 17.¹⁸ Liraglutide (Saxenda, and products such as Erly) is supplied at 6mg/ml and is a daily injection.

Tablet versions of GLP-1 treatment also exist, namely Wegovy tablets and Foundayo, and their product information is published in the electronic medicines compendium.²⁰²¹ Their trial results should not be compared with Mounjaro's, because no trial has compared them directly. For current Wegovy options, see the Wegovy pen page.

Which one suits you is a prescriber decision based on your health, other medicines, preferences and previous experience. Some people prefer a weekly pen; others would rather avoid injections.

If you are already on one licensed medicine and wondering about changing, do not switch on your own. The decision involves choosing a sensible starting dose on the new medicine, and a prescriber should guide it. Our page on whether you can switch from one GLP-1 to another explains the thinking in more detail.

Stopping a medicine is also a decision to discuss, not to improvise. After a final tirzepatide dose, it takes roughly four to five weeks to clear the system, and nothing needs doing while it clears.¹

Whatever you choose, licensed treatment is used alongside a reduced-calorie diet and increased physical activity, and individual results vary.

11 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹